For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Maravai LifeSciences Holdings Inc’s stock clocked out at $8.43, down -2.09% from its previous closing price of $8.61. In other words, the price has decreased by -$2.09 from its previous closing price. On the day, 1.7 million shares were traded. MRVI stock price reached its highest trading level at $8.61 during the session, while it also had its lowest trading level at $8.365.
Ratios:
To gain a deeper understanding of MRVI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.47 and its Current Ratio is at 11.32. In the meantime, Its Debt-to-Equity ratio is 1.37 whereas as Long-Term Debt/Eq ratio is at 1.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Craig Hallum on April 10, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On December 12, 2023, BofA Securities Upgraded its rating to Buy which previously was Neutral and also lowered its target price recommendation from $10 to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 28 ’24 when GTCR INVESTMENT XI LLC sold 9,940,974 shares for $9.81 per share. The transaction valued at 97,570,660 led to the insider holds 20,150,005 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 2123727744 and an Enterprise Value of 1543518208. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.09 while its Price-to-Book (P/B) ratio in mrq is 2.72. Its current Enterprise Value per Revenue stands at 5.631 whereas that against EBITDA is -394.762.
Stock Price History:
Over the past 52 weeks, MRVI has reached a high of $14.88, while it has fallen to a 52-week low of $4.52. The 50-Day Moving Average of the stock is -6.20%, while the 200-Day Moving Average is calculated to be 9.81%.
Shares Statistics:
It appears that MRVI traded 2.19M shares on average per day over the past three months and 1987300 shares per day over the past ten days. A total of 132.23M shares are outstanding, with a floating share count of 109.45M. Insiders hold about 17.60% of the company’s shares, while institutions hold 88.16% stake in the company. Shares short for MRVI as of 1715731200 were 6743150 with a Short Ratio of 3.08, compared to 1713139200 on 6340947. Therefore, it implies a Short% of Shares Outstanding of 6743150 and a Short% of Float of 6.1300002.
